Navigation Links
Men's Health Policy Center Hosts Petition to Protest Government Barrier to Prostate Cancer Medications
Date:3/27/2008

WASHINGTON, March 27 /PRNewswire-USNewswire/ -- The Men's Health Policy Center, a new resource center affiliated with the Men's Health Network (MHN), announced today that they are hosting an online petition urging Congress to end a Centers for Medicare and Medicaid Services (CMS) practice that unfairly restricts prostate cancer patients' access to drug therapies.

"This petition allows people who are impacted by prostate cancer to raise their united voices and let their Congressional leaders know that they are opposed to this policy," said Theresa Morrow, Director of Marketing and External Relations for MHN. "In order to ensure the best quality of life, prostate cancer patients should be treated according to the most effective treatment for them as determined by their physician and not according to what is cheapest."

The policy, known as "least costly alternative" (LCA), allows CMS to deny the additional payment for certain cancer therapies based solely on cost with no consideration for the clinical recommendations given by a patient's own physician. Groups such as the National Prostate Cancer Coalition, the Prostate Health Education Network, and Us TOO have also urged Congress and the Administration to drop the LCA policy for prostate cancer therapies.

"As a prostate cancer survivor, I struggle daily with the emotional and financial ramifications of my illness, and the last thing I need to worry about is how to pay for the care that's best for me. I believe all men should have access to the full range of treatments available without the federal government coming in between my doctor and me," said William Palos, a survivor from Illinois. "With nearly 200,000 men diagnosed with this disease each year, I don't think we should be singled out and forced to settle for substandard care."

Prostate cancer is the most frequently diagnosed cancer among men and is the second leading cause of cancer death among men. This cancer disproportionate
'/>"/>

SOURCE Men's Health Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Siemens Installs First High-Definition PET-CT
2. Siemens Urological Systems Tap U.S. Market
3. Siemens Consortium to Construct Particle Therapy Center at the University Clinic of Schleswig-Holstein
4. Siemens Showcases Latest Ultrasound Technologies at AIUM 2008
5. Siemens Introduces New Dual Energy Applications to SOMATOM Definition
6. VIDEO from Medialink and Siemens: NFL Stars Stress the Importance of a Healthy Heart
7. Siemens Signs New Revenue Cycle Management Customers
8. Trial finds tenofovir gel safe for daily use and most women adhered to study regimens
9. Americans Believe Pettitte had Conversations with Clemens Regarding Both Players Use of HGH
10. Siemens Receives FDA Approval for the VERSANT 440 Molecular System
11. Specimens in BODY WORLDS Exhibitions Stem Primarily from German Body Donation Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...Ennis, P.A. is offering free nationwide confidenti... control pills who have suffered a Deep Vein Throm...ack or other related cardiac issues or had their G...800-856-6405 or go to the firm’s website at ...ase evaluation form. , (P...
(Date:11/25/2009)...tinelleMedicalInc.,aleadingmanufacturerofbreastMRI...eofnewleadingedgeclinicalapplicationsonitsAegis(TM...gicalSocietyofNorthAmerica(RSNA)annualmeetinginChi...tionsleveragetheuniquehighqualityimagesgeneratedby...ltipleimagingmodalitiesformulti-parametricassessme...
(Date:11/25/2009)...siness,andPressJoinEfforttoEducate ,, MEMPHIS,...NationalBipolarFoundationandtheMedicAlertFoundatio..."program,whichisnowbeingwidelyacceptedasapreventiv...onalBipolarFoundationreceivedaproclamationofendors...orofLouisianaMitchLandrieu.TheNationalBipolarFound...
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
(Date:11/25/2009)...gns of trouble with the H1N1 vaccine, , ...ing H1N1 swine flu pandemic may be driving a recen...ents, a U.S. health official said Wednesday. , ... infections around the country," Dr. Anne Schuchat... and Respiratory Diseases at the U.S. Centers for ...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...ovider of supplemental insurance helps single wome...ection , Chicago (PRWEB) .../ [Combined Insurance], a leading provider of sup...iliate Network), marks an opportune time each year...
...reported a breakthrough test on its mesothelioma b...oma cancer. Up to this point, the number one reaso...s due to the fact that it is often misdiagnosed. ...ioma blog readers of a new scientific test that ma...
... Medical,Center received the President,s Award fro... Health Systems (NAPH) for its response in providi...st year. This award has not,been given since 2002,...Center., Twin Cities area hospitals treated 126 v...
...ceuticals,Inc. (Nasdaq: VNDA ) announced today th... Food and Drug Administration (FDA) in response to...stigational atypical antipsychotic,that was review...r which the company reported,results in December, ...
...are expressed in millions of Mexican pesos as of D...me period of 2007, unless,otherwise stated. Figure...for basis points), - Sales for the quarter total... sales were 7.19%, - The operating margin for the...
...e CHA Women,s and,Children,s Hospital in Seoul, Ko...s worldwide to win the 2008, prestigious American ...Design Award. It is one of the more,than 15 projec...oupled with this esteemed award furthers KMD,s pos...
Other Medicine News:Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 2Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 3Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 4Health News:Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage 5Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 2Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 4Health News:President's Award Recognizes Hospital's Response to Bridge Collapse 2Health News:Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone 2Health News:Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone 3Health News:Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone 4Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 2Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 3Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 4Health News:KMD's CHA Hospital, Korea Wins 2008 AIA National Healthcare Award 2
(Date:11/25/2009)... FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-First...SX:HIN),aleadinginnovatorandprovideroflessinvasive...ionizingthetreatmentofadvancedheartfailure,todayan...onatthe21stAnnualPiperJaffrayHealthCareConferencea...isbeingheldattheNewYorkPalaceHotel,December1-2. ,...
(Date:11/24/2009)... PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHou...ollowinganautoaccident,wasactuallyfullyconsciousan...Americasegment.TheDynaVoxEyeMaxwasfeaturedintheseg...therconditionscanunlockcommunication. ,, WHEN:G...lineat www.dynavoxtech.com ,, WHO:RomHou...
(Date:11/24/2009)... FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Verm...panyfileditsPlanofReorganizationandDisclosureState...uptcyCourtfortheDistrictofDelaware.Ahearingtoconsi...duledforDecember8,2009,withthehearingontheconfirma...lancallsfortheCompanytopayallclaimsinfull.ThePlani...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3MedAssets Awards MEDmarketplace com Contract for Idle Capital Equipment Hospital Equipment and Supplies 49788 1MedAssets Awards MEDmarketplace com Contract for Idle Capital Equipment Hospital Equipment and Supplies 49788 2Experimental Urine Test Spots Appendicitis 49786 1Experimental Urine Test Spots Appendicitis 49786 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 1YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 3YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 4YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 5
...)--Jun 27, 2007 - Opexa,Therapeutics, Inc. (NASDAQ...commercialization of cell therapies, presented,pos... for Stem Cell,Research Annual Meeting (ISSCR) in ...at the 13th Annual Meeting of the International,So...alia from June,24-27. The two presentations covere...
...007 - Gentium S.p.A. (Nasdaq:,GENT) announced the ... that support the safety, activity, synergy and po...ination with anticancer,therapy in multiple myelom... Company,s ongoing Phase I/II clinical trial for p...ma with Defibrotide in,combination with chemothera...
Other Medicine Technology:Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 2Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 3Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
Sota Omoigui's Anesthesia Drugs Handbook
A to Z Drug Facts, 6th Edition
...f new measuring principle - Pupil Zone Imaging Met...curacy and reliability in refraction measurement.,...ovides ordinary measurement (3.3 mm) using a mire ... 4 points, both of which offer reliable and accura...
ISI Free-Standing Arm Table
Medicine Products: